Akero Therapeutics, Inc. Operating Income
Akero Therapeutics, Inc. reported Operating Income of -$90.24 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-11-07
- Akero Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$90.24M.
- Akero Therapeutics, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$80.87M.
- Akero Therapeutics, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$80.88M.
- Akero Therapeutics, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$78.03M.
- Akero Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$285.42M.
- Akero Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$172.87M.
- Akero Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$115.16M.
- Akero Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$100.89M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$90.24M 10-Q · filed 2025-11-07 | -$171.11M derived: sum of 2 quarters · filed 2025-11-07 | -$251.99M 10-Q · filed 2025-11-07 | -$330.02M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | -$80.87M 10-Q · filed 2025-08-08 | -$161.75M 10-Q · filed 2025-08-08 | -$239.78M derived: sum of 3 quarters · filed 2025-08-08 | -$321.48M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | -$80.88M 10-Q · filed 2025-05-12 | -$158.91M derived: sum of 2 quarters · filed 2025-05-12 | -$240.61M derived: sum of 3 quarters · filed 2025-11-07 | -$306.35M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | -$78.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$159.73M derived: sum of 2 quarters · filed 2025-11-07 | -$225.47M derived: sum of 3 quarters · filed 2025-11-07 | -$285.42M 10-K · filed 2025-02-28 |
| 2024-09-30 | -$81.70M 10-Q · filed 2025-11-07 | -$147.44M derived: sum of 2 quarters · filed 2025-11-07 | -$207.40M 10-Q · filed 2025-11-07 | -$269.27M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$65.74M 10-Q · filed 2025-08-08 | -$125.69M 10-Q · filed 2025-08-08 | -$187.57M derived: sum of 3 quarters · filed 2025-08-08 | -$234.18M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$59.95M 10-Q · filed 2025-05-12 | -$121.83M derived: sum of 2 quarters · filed 2025-05-12 | -$168.44M derived: sum of 3 quarters · filed 2025-05-12 | -$204.07M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$61.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$108.49M derived: sum of 2 quarters · filed 2025-02-28 | -$144.12M derived: sum of 3 quarters · filed 2025-02-28 | -$172.87M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$46.62M 10-Q · filed 2024-11-08 | -$82.24M derived: sum of 2 quarters · filed 2024-11-08 | -$111.00M 10-Q · filed 2024-11-08 | -$136.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$35.63M 10-Q · filed 2024-08-09 | -$64.38M 10-Q · filed 2024-08-09 | -$89.80M derived: sum of 3 quarters · filed 2025-02-28 | -$125.89M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$28.75M 10-Q · filed 2024-05-10 | -$54.17M derived: sum of 2 quarters · filed 2025-02-28 | -$90.26M derived: sum of 3 quarters · filed 2025-02-28 | -$117.86M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$25.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$61.51M derived: sum of 2 quarters · filed 2025-02-28 | -$89.11M derived: sum of 3 quarters · filed 2025-02-28 | -$115.16M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$36.09M 10-Q · filed 2023-11-13 | -$63.69M derived: sum of 2 quarters · filed 2023-11-13 | -$89.74M 10-Q · filed 2023-11-13 | -$122.17M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$27.59M 10-Q · filed 2023-08-11 | -$53.65M 10-Q · filed 2023-08-11 | -$86.08M derived: sum of 3 quarters · filed 2024-02-29 | -$110.44M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$26.05M 10-Q · filed 2023-05-15 | -$58.49M derived: sum of 2 quarters · filed 2024-02-29 | -$82.84M derived: sum of 3 quarters · filed 2024-02-29 | -$111.81M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$32.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$56.79M derived: sum of 2 quarters · filed 2024-02-29 | -$85.76M derived: sum of 3 quarters · filed 2024-02-29 | -$100.89M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$24.35M 10-Q · filed 2022-11-04 | -$53.32M derived: sum of 2 quarters · filed 2022-11-04 | -$68.45M 10-Q · filed 2022-11-04 | -$98.23M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$28.97M 10-Q · filed 2022-08-05 | -$44.09M 10-Q · filed 2022-08-05 | -$73.88M derived: sum of 3 quarters · filed 2022-08-05 | -$95.42M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$15.13M 10-Q · filed 2022-05-06 | -$44.91M derived: sum of 2 quarters · filed 2022-05-06 | -$66.45M derived: sum of 3 quarters · filed 2022-05-06 | -$82.90M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$29.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$51.32M derived: sum of 2 quarters · filed 2022-02-25 | -$67.78M derived: sum of 3 quarters · filed 2022-02-25 | -$80.15M 10-K · filed 2022-02-25 |
| 2020-09-30 | -$21.54M 10-Q · filed 2021-11-12 | -$37.99M derived: sum of 2 quarters · filed 2021-11-12 | -$50.37M 10-Q · filed 2021-11-12 | -$66.59M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$16.45M 10-Q · filed 2021-08-13 | -$28.83M 10-Q · filed 2021-08-13 | -$45.05M derived: sum of 3 quarters · filed 2022-02-25 | -$61.36M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$12.38M 10-Q · filed 2021-05-13 | -$28.60M derived: sum of 2 quarters · filed 2022-02-25 | -$44.91M derived: sum of 3 quarters · filed 2022-02-25 | -$52.52M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$16.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$32.53M derived: sum of 2 quarters · filed 2022-02-25 | -$40.14M derived: sum of 3 quarters · filed 2022-02-25 | -$45.65M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$16.31M 10-Q · filed 2020-11-12 | -$23.92M derived: sum of 2 quarters · filed 2020-11-12 | -$29.43M 10-Q · filed 2020-11-12 | -$32.40M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$7.61M 10-Q · filed 2020-08-12 | -$13.12M 10-Q · filed 2020-08-12 | -$16.09M derived: sum of 3 quarters · filed 2020-08-12 | -$17.82M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$5.51M 10-Q · filed 2020-05-13 | -$8.48M derived: sum of 2 quarters · filed 2020-05-13 | -$10.21M derived: sum of 3 quarters · filed 2020-05-13 | -$18.87M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$4.70M derived: sum of 2 quarters · filed 2020-03-16 | -$13.36M derived: sum of 3 quarters · filed 2020-03-16 | -$13.78M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$1.73M 10-Q · filed 2019-11-12 | -$10.39M derived: sum of 2 quarters · filed 2019-11-12 | -$10.81M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$8.66M 10-Q · filed 2019-08-12 | -$9.08M 10-Q · filed 2019-08-12 |